MK-0822

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-0822, covering 2010-05-13 to 2019-11-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018) [Phase 3]